Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Chemokine signaling pathway | R-HSA-168638 | map04062 | etidronic acid | 656575 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | etidronic acid | 656575 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | etidronic acid | 656575 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | etidronic acid | 656575 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | etidronic acid | 656575 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | etidronic acid | 656575 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | etidronic acid | 656575 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | etidronic acid | 656575 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | etidronic acid | 656575 | drug-path |
Shigellosis | 0 | map05131 | ciprofibrate | 2763 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | ciprofibrate | 2763 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ciprofibrate | 2763 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | ciprofibrate | 2763 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ciprofibrate | 2763 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ciprofibrate | 2763 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | ciprofibrate | 2763 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ciprofibrate | 2763 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | ciprofibrate | 2763 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | AR-A014418 | 15541 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | AR-A014418 | 15541 | drug-path |